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SUMMARY
This prospective cross-sectional study was aimed to evaluate
the prevalence of IgM and IgG anti-T. gondii antibodies
and the associated risk factors among healthy blood donors
in Kerman province, south-eastern Iran. Structured question-
naires (before the donors gave blood) were used to obtain
information on risk factors for infection. Totally, 500 serum
samples from healthy blood donors of Kerman Blood Trans-
fusion Organization (KBTO) at Kerman, Iran, were
screened for IgG and IgM anti-T. gondii antibodies by
enzyme-linked immunosorbent assay (ELISA) and Roche
Elecsys Toxo IgM assay. Real-time PCR was used to detect
DNA of T. gondii in the IgM-positive samples. Seropreva-
lence of IgG and IgM anti-T. gondii antibodies was 288%
and 32%, respectively. In the multiple logistic regression, it
could be observed that living in rural regions, having B blood
type, being in contact with cats, consuming raw vegetables
and raw milk/egg and doing agricultural activities were inde-
pendent risk factors for Toxoplasma seropositivity. T. gon-
dii DNA was also found in one (90%) of IgM-positive
samples. In this study, it was found that T. gondii infection
was present among healthy blood donors in south-east of
Iran. Therefore, it is suggested to design screening
programmes for preventing transfusion-transmitted
toxoplasmosis.
Keywords blood transfusion, IgG antibody, IgM antibody,
Real-Time PCR, toxoplasmosis
INTRODUCTION
Toxoplasma gondii is a ubiquitous obligatory intracellular
coccidian protozoan organism found throughout the world
that infects a wide range of warm-blooded animals and
approximately one-third of the world’s human population
(1). Seroprevalence of this infection varies widely between dif-
ferent countries (10–80%), depending on social and cultural
habits, geographic factors, climate and transmission routes
(2). The majority of toxoplasmosis among immunocompe-
tent people is usually asymptomatic and self-limiting; how-
ever, severe diseases and complications can occur in
immunocompromised individuals such as transplant recipi-
ents and patients with acquired immunodeficiency syndrome
and also congenitally infected children (3–6). Humans can be
typically infected by three main routes of transmission: (i)
ingestion of tissue cysts in raw or undercooked infected meat,
(ii) ingestion of food or water contaminated with sporulated
oocysts shed in the faeces of an infected cat, and (iii) congeni-
tally, vertical transmission from mother to foetus across the
placenta when she is formerly infected through one of the
above two routes during pregnancy (7, 8). In addition,
T. gondii infection can be transmitted by the whole blood or
white blood cell transfusions or organ transplantation from
seropositive donors to susceptible recipients (9–11). As a con-
siderable portion of blood donors is at the risk of toxoplas-
mosis, it is necessary to determine the seroprevalence in
donor population so that proper strategies can be adopted to
decrease the risk. So far, in various studies, the prevalence of
T. gondii antibodies among blood donors has been reported
in different regions of the globe (12–23). Nevertheless, the
prevalence of toxoplasmosis in healthy blood donors of Iran
remains uncertain. This cross-sectional study was aimed to
evaluate the prevalence of IgM and IgG anti-T. gondii anti-
bodies and the associated risk factors among healthy blood
donors in Kerman province, south-east of Iran.
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MATERIALS AND METHODS
Ethics
This study was approved by Ethics Committee of Kerman
University of Medical Sciences. In addition, a written
informed consent was obtained from all the participants
before blood sampling.
Study design
A prospective cross-sectional study was performed in the
five biggest blood centres of Kerman Blood Transfusion
Organization (KBTO) in Kerman province, Iran. This
province covers an area of 181 714 km2 with the popula-
tion of nearly 2 700 000 and is located in the south-east
of Iran (Figure 1). It is the largest province and includes
11% of the total area of the country. The major cities in
this province are Kerman, Sirjan Jiroft, Rafsanjan and
Bam. Its climate varies in different regions, depending on
the land relief. Northern, north-western and central areas
(Kerman, Shahr-e-Babak, Baft and Sirjan) experience a
dry and moderate climate, whereas southern and south-
eastern (Bam and Jiroft) parts have warm and relatively
humid weather.
Sample collection and participants
Totally, 500 serum samples were collected 2 days in week
from apparently healthy blood donors referred the five big-
gest blood centres of KBTO in Kerman, Iran, during the
period from May to November 2014. All the samples from
blood donors were routinely tested in terms of antibodies
against human immunodeficiency virus (HIV), hepatitis C
virus (HCV), hepatitis B virus surface antigen (HBsAg) and
Treponema pallidum infection. None of the blood donors
were seropositive for HIV, HCV, HBsAg and T. pallidum.
Questionnaire
The applied questionnaire (before the donors gave blood)
was based on demographic data including age, gender, edu-
cation, residence and blood group. Moreover, possible risk
factors, such as animal contacts (cats), raw/half-cooked
meat consumption (fish, lamb and beef), consumption of
raw vegetables and raw egg/milk, gardening or agriculture
activity, and blood transfusion, were also evaluated.
Serologic tests
Enzyme-linked immunosorbent (ELISA) test
To evaluate the anti-T. gondii antibodies, serum samples
were transported from the five blood centres to Parasitol-
ogy Laboratory, Department of Parasitology and Mycol-
ogy, Kerman University of Medical Sciences (Kerman,
Iran) and stored at 20°C until being tested. All the serum
samples were tested using the commercially available
ELISA kit (Dia.Pro, Milano, Italy). Analyses were per-
formed following the manufacturer’s instructions. On the
basis of the ELISA kit, positive results for IgG and IgM
were defined as values of ≥50 international units (IU)/mL
and index values of ≥06, respectively. Range of equivocal
results was from 25 to 50 IU/mL and index values of 05–
06 were assumed for IgG and IgM, respectively. Also, neg-
ative results were defined as <25 IU/mL and index values of
<05 were considered for IgG and IgM, respectively.
Roche Elecsys Toxo IgM assay
Considering low specificity of IgM in the ELISA test, all
IgM-positive samples were analysed by Roche Elecsys Toxo
Figure 1 Geographical locations where this
study was carried out.
© 2015 John Wiley & Sons Ltd, Parasite Immunology, 37, 362–367 363
Volume 37, Number 7, July 2015 Toxoplasma infection among blood donors
IgM assay (Roche Diagnostics, Mannheim, Germany)
according to the manufacturer’s recommendations. This
automated system is based on an electrochemiluminescence
immunoassay and is intended for use on Roche Elecsys and
Roche ‘cobas e’ immunoassay analysers for the in vitro
quantitative determination of IgM antibodies to T. gondii in
human serum. Results are expressed as a ratio (cut-off index
– signal sample/cut-off) in the IgM assay. Interpretation of
Roche results was based on the manufacturer’s criteria
which were classified as follows: <08 as nonreactive, ≥08 to
<10 as indeterminate and ≥10 as reactive.
Molecular diagnosis
Real-time PCR was used to detect DNA of T. gondii in the
IgM-positive samples. DNA from blood samples was iso-
lated using a high Pure PCR Template Preparation Kit
(Roche Applied Sciences) according to the manufacture’s
protocol. Real-time PCRwas performed using the iQ5 real-
time PCR detection system (Bio-Rad, Hercules, CA, USA),
and SYBR green was used to detect amplification products.
The primer used (Invitrogen, Carlsbad, CA, USA) ampli-
fied a 126-bp B1 gene region. The forward and reverse
sequences were 50-GGAGGACTGGCAACCTGGTGTCG-
30 and 50-TTGTTTCACCCGGACCGTTTAGCAG-30,
respectively. As positive control, T. gondii genomic DNA,
serially 10-fold diluted and ranging from 5000 to 05 para-
sites per microlitre (TIB MolBiol), and a negative control,
prepared by the substitution of template DNAwith distilled
water, were used in each Real-time PCR run. Finally, Data
analysis was performed using iQTM5 optical system software
(Bio-Rad).
Statistical analyses
Analytical and descriptive statistics was carried out using
SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). Descrip-
tive statistics were reported in terms of per cent (for categor-
ical) and mean (SD) (for continuous) variables. Chi-square
test was applied to access the univariate association between
independent variables and outcome. Multifactorial logistic
regression models were used to evaluate association between
T. gondii seropositivity and the potential risk factors.
P < 0.05 was considered to be statistically significant.
RESULTS
Participants
A total of 500 blood donors were included in the present
study; the mean age of the participants was 289 years
(ranging from 18 to 57). Most participants were men
(910%), aged 18–25 years, living in urban areas, who had
college education or above.
Seroprevalence of anti-T. gondii antibodies
Of the 500 blood donors, 160 (320%) tested seropositive for
anti-T. gondii antibodies, 144 (288%) donors tested sero-
positive for IgG antibody, 5 (10%) tested seropositive for
both IgM and IgG, and 11 (22%) were positive for IgM
antibody alone. Thus, the prevalence rates of IgG and IgM
anti-T. gondii antibodies were 288% and 32%, respectively.
In terms of geographical region, seroprevalence of anti-
T. gondii IgG antibody in five blood centres including Ker-
man, Sirjan, Rafsanjan, Bam and Jiroft were 326%, 292%,
277%, 209% and 317%, respectively. For gender, seropre-
valence of anti-T. gondii IgG antibody was significantly
higher among female donors. Twenty (444%) female donors
were positive in terms of IgG anti-T. gondii antibodies com-
pared to 124 (272%) male donors (P < 005). In contrast,
there was no significant difference in the prevalence of IgM
anti-T. gondii among the female (44%) and male (30%)
donors (P = 0811). Furthermore, chi-square test for trend
revealed that seroprevalence of IgG and IgM anti-T. gondii
antibodies increased with age (P = 004) (Table 1).
Roche elecsys toxo IgM assay
Due to low specificity of IgM antibody in the ELISA test,
Roche Elecsys Toxo IgM assay with higher sensitivity and
specificity was used in the 16 (32%) IgM-positive samples.
Results showed that 1 (02%) sample tested with Elecsys
assay were nonreactive, while 15 (30%) samples tested
were reactive.
Risk factors of being anti-T gondii antibodies
Table 2 shows the associations between risk factors, status
of anti-T. gondii IgG antibodies in the univariate analysis
(crude OR) and also multiple logistic regression (adjusted
OR). Variables used in the adjusted model were age, gender,
education, residence, blood group, animal contacts, raw/
half-cooked meat consumption, consumption of raw vege-
tables and raw egg/milk, gardening or agriculture activity,
and blood transfusion. Several risk factors which were sig-
nificantly related to T. gondii seropositivity (at least one of
the IgG and IgM being positive) in the univariate analysis
at P < 005 included gender of female (P = 0021), age of
more than 45 years old (P = 0032), living in rural regions
(P < 0001), having B blood type (P = 0005), contact with
cats (P < 0001), raw/half-cooked meat consumption
(P = 0015), consumption of raw vegetables (P = 0015)
and agricultural activities (P < 0001). However, other
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demographic and risk factors of the blood donors did not
show any association with T. gondii seropositivity (Table 2).
In multiple logistic regression, it could be observed that liv-
ing in rural regions, having B blood type, being in contact
with cats, consuming raw vegetables and raw milk/egg and
doing agricultural activities were independent risk factors
for Toxoplasma seropositivity.
Real-time PCR
All IgM-positive samples were tested using the real-time
PCR assays for the presence of T. gondii DNA. T. gondii
DNA was found in one (90%) of IgM-positive samples.
However, correlation between IgM positivity and PCR
results was not statistically significant (P > 005).
DISCUSSION
Toxoplasma gondii infection as a bloodborne disease can
lead to significant clinical consequences among blood recip-
ients, especially in immunocompromised, multiply trans-
fused patients, pregnant women, foetus, etc. (3–8). As the
Table 1 Demographic characteristics and T. gondii seroprevalence
among healthy blood donors in Kerman province, Iran
Variables No. (%)
IgG
positive
IgM
positive
At least one
positive
Gender
Male 455 (910) 124 (273) 14 (31) 135 (297)
Female 45 (90) 21 (467) 2 (44) 21 (467)
Age groups
<25 years 217 (434) 57 (263) 5 (23) 60 (276)
26–35 180 (36) 51 (283) 6 (33) 57 (317)
36–45 76 (152) 24 (316) 4 (53) 26 (342)
>45 years 27 (54) 13 (481) 1 (37) 13 (481)
Residential place
Urban 388 (776) 91 (235) 13 (34) 101 (26)
Rural 112 (224) 54 (482) 3 (27) 55 (491)
Education
Less than
diploma
254 (508) 79 (311) 8 (31) 85 (335)
Diploma
and above
246 (492) 66 (268) 8 (33) 71 (289)
Blood type
A 154 (308) 41 (266) 4 (26) 43 (279)
B 36 (72) 18 (500) 1 (28) 19 (528)
AB 83 (166) 28 (337) 3 (36) 29 (349)
O 227 (454) 58 (256) 8 (35) 65 (286)
Being in contact with cat
No 311 (622) 66 (212) 6 (19) 71 (228)
Yes 189 (378) 79 (418) 10 (53) 85 (45)
Raw/half-cooked meat consumption
No 440 (880) 118 (268) 13 (30) 129 (293)
Yes 60 (120) 27 (450) 3 (50) 27 (450)
Eating uncooked vegetables
No 100 (200) 19 (190) 2 (20) 21 (210)
Yes 400 (800) 126 (315) 14 (35) 135 (338)
Gardening or agriculture
No 407 (814) 97 (238) 11 (27) 105 (258)
Yes 93 (186) 48 (516) 5 (54) 51 (548)
Raw milk/egg consumption
No 444 (888) 123 (277) 12 (27) 131 (295)
Yes 56 (112) 22 (393) 4 (71) 25 (446)
Blood transfusion
No 488 (976) 143 (293) 16 (327) 155 (318)
Yes 12 (24) 2 (166) 0 (00) 2 (166)
Table 2 Univariate (crude OR) and multiple (adjusted OR)
logistic regression analysis of the potential factors associated with
T. gondii IgG seroprevalence among healthy blood donors in
Kerman province, Iran
Variables
IgG positive
Crude OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Gender
Male 1 – 1 –
Female 23 (13, 43) 0007* 21 (11, 42) 0034*
Age groups
<25 years 1 – 1 –
26–35 11 (07, 17) 064 10 (06, 16) 095
36–45 13 (07, 23) 037 09 (05, 17) 068
>45 years 26 (11, 58) 002* 20 (08, 48) 014
Residential place
Urban 1 – 1 –
Rural 30 (19, 47) <0001* 20 (12, 33) 0006*
Education
Diploma
and above
1 – 1 –
Less than
diploma
12 (08, 18) 029 12 (08, 19) 038
Blood type
A 1 – 1 –
B 27 (13, 58) 0008* 23 (10, 53) 0044*
AB 14 (078, 25) 025 14 (07, 26) 029
O 094 (059, 15) 081 08 (05, 13) 040
Being in contact with cat
No 1 1 1 1
Yes 26 (18, 39) <0001* 23 (15, 36) <0001*
Raw/half-cooked meat consumption
No 1 – 1 –
Yes 22 (13, 38) 0004* 17 (09, 31) 010
Eating uncooked vegetables
No 1 – 1 –
Yes 196 (11, 33) 0015* 18 (10, 33) 0038*
Gardening or agriculture
No 1 – 1 –
Yes 34 (21, 54) <0001* 22 (13, 38) 0003*
Raw milk/egg consumption
No 1 – 1 –
Yes 17 (095, 31) 0074 15 (08, 29) 018
Blood transfusion
No 1 – 1 –
Yes 14 (10, 22) 035 140 (11, 23) 04
* P < 0.05 was statistically significant.
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existing therapies are not fully effective and no safe and
efficacious vaccines are available, it is crucial to make
efforts for reducing toxoplasmosis transmission to diminish
the severe complication of toxoplasmosis. In the present
study, it was found that 320%, 288%, 10% and 22% of
donors tested were positive for anti-T. gondii antibodies,
only IgG antibody, both IgM and IgG, and IgM antibody
alone. However, due to low specificity of IgM in the ELISA
test, all IgM-positive samples were analysed by Roche Elec-
sys Toxo IgM assay based on an electrochemiluminescence
immunoassay. The results obtained in this assay demon-
strated that 1 (02%) sample tested with Elecsys assay was
nonreactive, while 15 (30%) samples tested were reactive.
In line with these findings, Prusa et al. (2010) reported that
Elecsys assay is a useful tool as a first-line screening
method to detect Toxoplasma infections with high sensitiv-
ity and specificity of 971% and 1000%, respectively (24).
The present findings revealed that both contact with
cats and consumption of raw/half-cooked meat are signifi-
cant risk factors for T. gondii seropositivity, which exhibits
that, among the blood donors in this study, both infection
routes, the ingestion of oocysts (animal to human trans-
mission) and that of tissue cysts in meat (foodborne trans-
mission), existed, similar to the infection routes reported
in other studies (23, 25, 26). The prevalence of T. gondii
seropositivity was similar to the seroprevalence reported in
Czech Republic (17) and Mexico (20) and higher than
those reported previously in Turkey (19), Mexico (22),
India (12), north-east of Thailand (21), and Taiwan (15).
However, it was less than the one reported among blood
donors in central Iran (26), male blood donors in north-
east of Brazil (27), north of India (16), and Egypt (13),
where the seroprevalence of T. gondii has varied from 50
to 750%. These variations in the prevalence of T. gondii
among the blood donors might be related to sociocultural
habits, geographical and environmental factors, and trans-
mission routes in the studied population (13, 22). In the
present study, similar to the work conducted by Elhence
et al. (16), seroprevalence of T. gondii in female donors
was significantly higher than that in males. But, it was in
contrast to the results of Sundar et al. (12) and Ormazdi
et al. (26). Such significant difference could be attributed
to greater exposure of females to oocysts and tissue cysts
during their daily activities. However, due to the small
number of female donors in the present study, the results
need to be confirmed on a larger sample size. This investi-
gation exhibited that rate of seropositivity increased with
age as a consequence of increased opportunity for expo-
sure; such a finding was in agreement with those observed
in other studies (13, 22, 27). No difference was found
between education, raw milk/egg consumption and blood
transfusion on the one hand and seroprevalence of
anti-T. gondii antibodies on the other. Interestingly, the
present study for the first time demonstrated a significant
correlation between T. gondii seropositivity and blood
group B (P = 0008). As this correlation may be accidental
or accounted for by biased sampling, further studies are
required to elucidate this correlation in more depth.
In addition, it was observed that risk of T. gondii was
higher in the donors living in rural (P < 0001) than those
living in urban regions. This significant difference could be
attributed to occupational activities related to contact with
animals and having lower socio-economic and lower hygie-
nic lifestyle levels as described elsewhere (16). In this
investigation, similar to the previous studies, it was identi-
fied contact with cats, raw/half-cooked meat consumption,
consumption of raw vegetables and agricultural activities
(as potential risk factors for acquiring toxoplasmosis) were
associated with the seropositivity of T. gondii (16, 22, 23).
Our findings also demonstrated that T. gondii DNA was
found in one (90%) of IgM-positive samples; therefore,
the presence of parasitemia confirmed by PCR in IgM-
positive healthy blood donors ensures the likelihood of
transmission of Toxoplasma through blood transfusion.
However, some factors such as the short duration of para-
sitemia and the low numbers of trophozoites circulating in
peripheral blood could lead to a sampling error that will
produce false-negative results in such cases (28).
To conclude, in this study, it was found that T. gondii
infection was prevalent among healthy blood donors in the
south-east of Iran with the overall seroprevalence rate of
32%. These results also showed that both infection routes
(ingestion of oocysts and that of tissue cysts) existed in the
blood donors of this region. Moreover, it was observed that
anti-T. gondii IgM seroprevalence among blood donors
included in the present study had a high considerable rate.
Regarding the presence of immunosuppressed and organ
transplant patients who are hospitalized in the studied area
and their constant need for blood and blood products,
therefore, the results of this study can be a warning for
blood transfusion organizations in order to pay special
attention to toxoplasmosis among blood donors and also
design screening programmes for prevention transfusion-
transmitted toxoplasmosis.
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